In our laboratory, administration of Valproic Acid, a class I and II HDACi, potently upregulated PD-L1 surface protein expression and RNA transcription in a time- and concentration-dependent fashion in ovarian cancer, via a mechanism that likely involves STAT signaling [51]. This evidence concerns the gene CD274 and ovarian cancer.